| Years | Title | |
| 2000-2008 | Phase IV Registry of etanercept (Enbrel) in children with Juvenile Rheumatoid Arthritis. Data submitted for publication | |
| | | |
| 2005-2008 | A Pilot, Multi-Center, Randomized, Double Blind, Placebo Controlled, Ascending Dose, Safety, Tolerability and Preiminary Efficacy Study of Two Dose Levels of IL-1 Trap Administered Subcutaneously in Pediatric Subjects with Active Systemic Juvenile Idiopathic Arthritis (SJIA) | |
| | | |
| 2002-2004 | Clinical Protocol for a Randomized, Double-blind Multi-center, Active Controlled Parallel Group Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients with JRA | |
| | | |
| 2002-2003 | Efficacy and Safety of Leflunomide versus Methorexate Comparison in Patients with Juvenile Rheumatoid Arthritis (JRA) | |
| | | |
| 2001-2003 | A Randomized, Double-blind Trial of Anti-TNF alpha Chimeric Monoclonal Antibody (INFLIXIMAB) in Combination with Methotrexate for the Treatment of Patients with Polyarticular JRA | |
| | | |
| 2001- | A 52-Week, Open Label, Active Comparator Controlled Extension to a 12-Week Trial of Rofecoxib in Juvenile Rheumatoid Arthritis Patients | |
| | | |
| 2000- | A 12-Week Double-Blind Randomized Trial, With a 12-Week Open Label Extension, to Investigate Efficacy and Safety of Meloxicam Oral Suspension Administered Once Daily and Naproxen Oral Suspension Administered Twice Daily in Children With JRA. | |
| | | |
| 2000- | Safety and Efficacy of Meloxicam Oral Suspension in JRA (Subtrial of 107.208) | |
| | | |
| 2000-2003 | Development and Validation of Core Sets of Outcome Measures and Definitions of Improvement for Juvenile Dermatomyositis and Juvenile Systemic Lupus Erythematosus | |
| | | |
| 2000-2003 | A Randomized, Multi-center, Blinded, Placebo-controlled Study with an Open Label Run-in Period to Evaluate the Efficacy, Safety & Pharmacokinetics of Daily, Single, Subcutaneous Injections of r-metHUlL-Ira (Anakinra) in Polyarticular Course JRA | |
| | | |
| 2000-2003 | A Companion Extension Study to Evaluate the Long-term Safety of Daily, Single, Subcutaneous injections of r-metHulL-1ra (Anakinra) in Subjects with Polyarticular Course JRA who participated in IL-1ra (Protocol 990758) | |
| | | |
| 1999- | An Open, Oral Dose Study to Evaluate the Steady State Plasma Concentration Profile of MK-0966, Followed by a 12-Week, Double-blind, Active-comparator-controlled Extension, in Late- and Post-pubertal Adolescents With Juvenile Rheumatoid Arthritis | |
| | | |
| 1999-2000 | Therapeutic Exploratory Trial of Cosamin DS in JRA | |
| | | |
| 1999-2002 | Neoral in Polyarticular Course JRA: Post-marketing Surveillance | |
| | | |
| 1998-2000 | Parenteral Methotrexate in Medium versus High-dosed for the Treatment of Idiopathic Arthritis of Childhood | |
| | | |
| 1998-1999 | Phase I Trial - Leflunomide in Poly course JRA | |
| | | |
| 1997-1998 | Safety, Population PK and Efficacy of Recombinant Human Tumor Necrosis Factor Receptor (P75) Fc Fusion Protein (TNFR:Fc) in Children with JRA | |
| | | |
| 1997- | Open-label Treatment with TNFR:Fc in JRA | |
| | | |
| 1995-1996 | A Double-blind, Randomized, Vehicle-controlled, Parallel Group Multi-center Pilot Study Evaluating the Safety and Efficacy of Civamide Cream, 0.075% in Children with Pauciarticular Juvenile Rheumatoid Arthritis Disease of the Knee | |
| | | |
| 1994-1996 | Phase I/II study of DAB389IL-2 Fusion Toxin in Patients with Severe Polyarticular Juvenile Rheumatoid Arthritis | |
| | | |
| 1992-1996 | Intravenous Gammaglobulin (IVEEGAM) in Polyarticular Juvenile Rheumatoid Arthritis | |
| | | |
| 1990-1992 | Intravenous Gammaglobulin in Severe Polyarticular JRA Patients | |
